Abstract:ABSTRACT Background β-Glucans (BGs), a group of complex non-digestible polysaccharides, are considered to have beneficial health effects due to their immune modulatory properties and are considered as dietary supplements. However, the impact of oral administration of high-pure, well-defined BGs on gut inflammation, and the influence of intestinal microbiota and short-chain fatty acid (SCFA) on the therapeutic effect are largely unknown. Objectives The aim of this study, using a mouse model of chemical induced colitis, was to investigate the impact of oral administration of high-pure yeast BG (YBG) on the susceptibility to colitis, gut immune function, and structure and function of microbiota. Methods To determine the impact of oral administration of YBG on colitis susceptibility, eight week old C57BL/6 (B6) mice were pre-treated with YBG (250 μg/mouse/day) and given dextran sulfate sodium (DSS) in drinking water (2.5% w/v) and examined for the symptoms and features of colitis. To assess the effect of oral administration of YBG on gut mucosa and microbiota structure and function, and gut immune regulation, we determined the microbiota composition, fecal SCFA levels, and intestinal T cell phenotype and cytokine secretion. The role of gut microbiota in YBG treatment induced modulation of gut inflammation and immune function were determined in B6 mice treated with broad-spectrum antibiotic cocktail (1 g/L ampicillin, 0.5 g/L vancomycin, 1 g/L neomycin, and 1 g/L metronidazole) in drinking water. Results Compared to untreated mice, B6 mice that received prolonged pre-treatment with YBG showed diminished severity of different features of DSS-induced colitis including overall loss of body weight ( P <0.001), shortening of colon ( P =0.016) and histopathology ( P =0.01). However, high-pure YBG has no beneficial effect in terms of suppressing colitis severity when consumed only during the disease stage. Compared to untreated controls, YBG pre-treated mice showed higher regulatory T cell (Treg) frequencies ( P =0.043) in the gut mucosa, a shift in the abundance of gut microbiota towards polysaccharide-fermenting bacterial phyla Bacteroides ( P =0.049) and Verrucomicrobia (Mean±SD: control=13.0±0.33 vs YBG=10.9.7±0.69) and diminished Firmicutes ( P <0.001) and Proteobacteria ( P <0.001), and significantly higher production of SCFA such as acetic acid ( P =0.016), propionic acid ( P =0.026) and butyric acid ( P =0.013). Depletion of gut microbiota in YBG-fed B6 mice using broad spectrum antibiotics caused not only elimination of YBG treatment associated SCFA production and Treg increase, but also profound aggravation of the pathological features of colitis such as loss of body weight ( P <0.01) and colonic inflammation ( P =0.04) compared to that of YBG treated control mice. Conclusions Oral consumption of high-pure BG promotes a healthy gut homeostasis and immune regulation, and minimizes susceptibility to DSS induced colitis in B6 mice in a microbiota (and microbial SCFA) - dependent manner. On the contrary, YBG consumption when gut mucosa and microbiota are compromised not only reverses this protection but also increases the susceptibility to gut inflammation and disease severity, perhaps through its direct interaction with gut immune cells. In conclusion, while YBG consumption may be beneficial for gut health and to prevent gut inflammation in healthy individuals and under intact microbiota, this immune stimulatory dietary supplement may not have any health benefits in individuals with active gut inflammation and could cause adverse effect in those who are on oral antibiotics.

β-glucan mitigates ovalbumin-induced airway inflammation by preventing oxidative stress and CD8+ T cell infiltration

β-glucan nanoparticles alleviate acute asthma by suppressing ferroptosis and DNA damage in mice

The effects of neutralizing anti-murine interleukin-17A monoclonal antibody on ozone-induced inflammation and glucocorticoids insensitivity in a murine model of asthma

Pretreatment with yeast derived complex dietary-polysaccharide leads to suppressed gut inflammation, altered microbiota composition and increased immune regulatory short-chain fatty acid production in C57BL/6 mice

β-Glucan from Saccharomyces cerevisiae alleviates oxidative stress in LPS-stimulated RAW264.7 cells via Dectin-1/Nrf2/HO-1 signaling pathway

Protective effects of glaucocalyxin A on the airway of asthmatic mice

Wogonoside Ameliorates Airway Inflammation and Mucus Hypersecretion via NF-κB/STAT6 Signaling in Ovalbumin-Induced Murine Acute Asthma

Exposure to structurally unique β-d-glucans differentially affects inflammatory responses in male mouse lungs

Inhibition of γ-glutamyl transferase suppresses airway hyperresponsiveness and airway inflammation in a mouse model of steroid resistant asthma exacerbation

β-Glucans are involved in immune-modulation of THP-1 macrophages

The Effects of Chrysophanol on Ovalbumin (Ova)-Induced Chronic Lung Toxicology by Inhibiting Th17 Response

Sophoraflavanone G from Sophora flavescens Ameliorates Allergic Airway Inflammation by Suppressing Th2 Response and Oxidative Stress in a Murine Asthma Model

Effect of Bacillus Calmette-Guerin Treatment on Airway Inflammation and T Regulatory Cells in Mice with Asthma

Oat β-(1 → 3, 1 → 4)-d-glucan alleviates food allergy-induced colonic injury in mice by increasing Lachnospiraceae abundance and butyrate production

Whole β-glucan particle attenuates AOM/DSS-induced colorectal tumorigenesis in mice via inhibition of intestinal inflammation

Beta 1,3-1,6 Glucans Produced by Two Novel Strains of Aureobasidium Pullulans Exert Immune and Metabolic Beneficial Effects in Healthy Middle-aged Japanese Men: Results of an Exploratory Randomized Control Study

Enhanced Immunomodulatory Properties of Ovalbumin Through Transglutaminase and Tyrosinase/caffeic Acid-Catalyzed Crosslinking Plus Galactomannan Conjugation Alleviates Allergic Asthma

Effects of Bacillus Calmette-Guerin on airway inflammation, T helper cell differentiation and serum OVA-specific IgE levels in a mouse model of asthma

Glutathione ethyl ester supplementation prevents airway hyper-responsiveness in mice

Characterization of the Immune-Modulating Properties of Different β-Glucans on Myeloid Dendritic Cells

Therapeutic Potential of Anti-Il-1β IgY in Guinea Pigs with Allergic Asthma Induced by Ovalbumin